ARN2966
CAS: 102212-26-0
Ref. 3D-CEA21226
1g | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued | ||
100mg | Discontinued |
Product Information
ARN2966 is a novel small molecule that has been shown to inhibit the production of inflammatory messengers, such as prostaglandins and leukotrienes. It is a member of the class of non-steroidal anti-inflammatory drugs (NSAIDs) that are used to treat conditions such as arthritis and pain. ARN2966 has been shown to have an inhibitory effect on chronic inflammation in animal models, but its mechanism of action remains unclear. ARN2966 has been tested in clinical trials in humans for the treatment of osteoarthritis and rheumatoid arthritis with promising results. Further research is required to determine how ARN2966 exerts its effects on cells and tissues.